Medivir to present at the Erik Penser Bank Company Day
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Erik Penser Bank Company Day on August 24, 2022. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox).The presentation will be available after the meeting on Medivirs website; www.medivir.com.For additional information, please contactMagnus Christensen, CFO, Medivir ABTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.comMedivir in briefMedivir develops innovative drugs with a focus